English | Español
Press release submission | Mar 15, 2019

AMGEN, INC.: Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke
Karen Kidd | Mar 11, 2019

New technologies can treat anxiety, depression through at-home brain stimulation
Press release submission | Mar 7, 2019

ALLERGAN, PLC: FDA Accepts Supplemental Biologics License Applications (sBLAs) for BOTOX® (onabotulinumtoxinA) for Pediatric Patients with Upper and Lower Limb Spasticity
Press release submission | Feb 27, 2019

INNOVENT BIOLOGICS, INC.: First Patient Dosed in a Clinical Trial of Tyvyt® (Sintilimab injection) in Combination with IBI305 as First Line Treatment for Patients with Advanced Hepatocellular Carcinoma
Press release submission | Feb 21, 2019

AIVITA BIOMEDICAL, INC.: Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial
Press release submission | Feb 21, 2019

VRHEALTH: Breast Cancer Patients Cut Hot Flashes and Night Sweats by Half with VR-AI Therapy from VRHealth, Report Finds

Press release submission | Feb 14, 2019

TROVAGENE, INC.: Presents Update on Phase 2 Study of Onvansertib in Combination with Zytiga in Patients with mCRPC at ASCO-GU Conference
Kyla Asbury | Feb 7, 2019

Brain stimulator produces positive, lasting results with almost no side effects

Trending
+ Regulatory
Patient Daily | Mar 4, 2025

Poll: Two-thirds of Americans, including 58% of Trump voters, say SNAP benefits should cover soft drinks
+ Pharmaceuticals
Patient Daily | Mar 5, 2025

Tips for breaking in cowboy boots shared by Baylor College of Medicine podiatrist